Dabigatran-induced Vasculitis on the Palms: A Case Report and Review of Literature
Dabigatran is one of the newer nonvitamin K antagonist oral anticoagulants and has been approved for atrial fibrillation and prevention of venous thromboembolism. Till date, very few cases of dabigatran-induced leukocytoclastic vasculitis (LCV), also known as hypersensitivity vasculitis or hypersens...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Clinical Dermatology Review |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/cdr.cdr_116_22 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Dabigatran is one of the newer nonvitamin K antagonist oral anticoagulants and has been approved for atrial fibrillation and prevention of venous thromboembolism. Till date, very few cases of dabigatran-induced leukocytoclastic vasculitis (LCV), also known as hypersensitivity vasculitis or hypersensitivity angiitis, have been described in the literature. We present the case of a 50-year-old male with deep vein thrombosis who developed palpable purpura and petechiae over the palms after dabigatran initiation. The present case highlights dabigatran as a potential risk for LCV, the rare site of LCV over the palms, and also provides insight into management and further evaluation. |
|---|---|
| ISSN: | 2542-551X 2542-5528 |